Clinical Trials Logo

Clinical Trial Summary

This is a prospective multi-centre, Open-Label Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT7104 in Patients with Advanced Solid Tumours in Australia.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05200013
Study type Interventional
Source Bio-Thera Solutions
Contact Lesley Liu
Phone +86-20-32203220
Status Recruiting
Phase Phase 1
Start date April 29, 2022
Completion date December 31, 2024